Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :28766343
Publication Date : //

Isothermal Point Mutation Detection: Toward a First-Pass Screening Strategy for Multidrug-Resistant Tuberculosis.


Point mutations in DNA are useful biomarkers that can provide critical classification of disease for accurate diagnosis and to inform clinical decisions. Conventional approaches to detect point mutations are usually based on technologies such as real-time polymerase chain reaction (PCR) or DNA sequencing, which are typically slow and require expensive lab-based equipment. While rapid isothermal strategies such as recombinase polymerase amplification (RPA) have been proposed, they tend to suffer from poor specificity in discriminating point mutations. Herein, we describe a novel strategy that enabled exquisite point mutation discrimination with isothermal DNA amplification, using mismatched primers in conjunction with a two-round enrichment process. As a proof of concept, the method was applied to the rapid and specific identification of drug-resistant Mycobacterium tuberculosis using RPA under specific conditions. The assay requires just picogram levels of genomic DNA input, is sensitive and specific enough to detect 10% point mutation loading, and can discriminate between closely related mutant variants within 30 min. The assay was subsequently adapted onto a low-cost 3D-printed isothermal device with real-time analysis capabilities to demonstrate a potential point-of-care application. Finally, the generic applicability of the strategy was shown by detecting three other clinically important cancer-associated point mutations. We believe that our assay shows potential in a broad range of healthcare screening processes for detecting and categorizing disease phenotypes at the point of care, thus reducing unnecessary therapy and cost in these contexts.

Authors : Ng Benjamin Y C , Wee Eugene J H , Woods Kyra , Anderson Will , Antaw Fiach , Tsang Hennes Z H , West Nicholas P , Trau Matt ,

Related products :

Catalog number Product name Quantity
HPAI-I91L Human PAI-1 (point mutation stable form) 1.0 mg
HPAI-I91L PAI - 1 Human PAI-1 (point mutation stable form) 1.0 mg
HPAI-I91L Human PAI-1 (point mutation stable form) 0.5 mg
ASK-7020 CRISPRCLEAR Transfection Ready Point Mutation Kit (Validated) 1 Kit
HPAI-I91L PAI - 1 Human PAI-1 (point mutation stable form) 0.5 mg
HPAI-I91L Human PAI_1 (point mutation stable form) 0,5 mg
HPAI-I91L Human PAI_1 (point mutation stable form) 1,0 mg
ASK-7620 CRISPRCRITTERS Rat Embryo Injection Ready Point Mutation Kit (Validated) 1 Kit
ASK-7520 CRISPRCRITTERS Mouse Embryo Injection Ready Point Mutation Kit (Validated) 1 Kit
ASK-7022 CRISPRCLEAR Transfection Ready Point Mutation Kit (Cas9 H840A nickase) (Validated) 1 Kit
ASK-7621 CRISPRCRITTERS Rat Embryo Injection Ready Point Mutation Kit (Cas9 D10A) (Validated) 1 Kit
ASK-7021 CRISPRCLEAR Transfection Ready Point Mutation Kit (Cas9 D10A nickase) (Validated) 1 Kit
ASK-7521 CRISPRCRITTERS Mouse Embryo Injection Ready Point Mutation Kit (Cas9 D10A) (Validated) 1 Kit
ASK-7622 CRISPRCRITTERS Rat Embryo Injection Ready Point Mutation Kit (Cas9 H840A nickase) (Validated) 1 Kit
TM 1402 OXACILLIN RESISTANCE SCREENING AGAR BASE (for screening oxacillin resistant microorganisms.) 500 gm
B1240 Oxacillin Resistance Screening Agar Base USE : For screening oxacillin resistant microorganisms. 5x500gm
B1240 Oxacillin Resistance Screening Agar Base USE For screening oxacillin resistant microorganisms. Qty per Litre of Medium: 103.5/990ML
ASK-7522 CRISPRCRITTERS Mouse Embryo Injection Ready Point Mutation Kit (Cas9 H840A nickase) (Validated) 1 Kit
N-5814 Mycobacterium Tuberculosis (rpo Primer set 2) Bacteria Detection Diagnostic Detection Primers (2 nM each)
N-5820 Mycobacterium Tuberculosis, Bovis Bacteria Detection Diagnostic Detection Primers (2 nM each)
N-5813 Mycobacterium Tuberculosis (rpo Primer set 1) Bacteria Detection Diagnostic Detection Primers (2 nM each)
N-5821 Mycobacterium Tuberculosis, Bovis Bacteria Detection Diagnostic Detection Primers (2 nM each)
N-5912 Mycobacterium Tuberculosis Bacteria Detection Diagnostic Detection Primers (2 nM each)
N-5911 Mycobacterium Tuberculosis Bacteria Detection Diagnostic Detection Primers (2 nM each)
N-5910 Mycobacterium Tuberculosis Bacteria Detection Diagnostic Detection Primers (2 nM each)


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur